Development of Solid Lipid-polymer Hybrid Nanoparticles as Potential Oral Delivery Systems for Lipophilic Bioactive Compounds

Development of Solid Lipid-polymer Hybrid Nanoparticles as Potential Oral Delivery Systems for Lipophilic Bioactive Compounds
Author: Taoran Wang
Publisher:
Total Pages:
Release: 2019
Genre: Electronic dissertations
ISBN:

Download Development of Solid Lipid-polymer Hybrid Nanoparticles as Potential Oral Delivery Systems for Lipophilic Bioactive Compounds Book in PDF, Epub and Kindle

Solid lipid-polymer hybrid nanoparticles (SLPN) are nanocarriers made from a combination of polymers and lipids. By integrating the advantages of biocompatible lipid-based nanoparticles and gastrointestinal (GI)-stable polymeric nanoparticles, SLPN are the ideal delivery system for delivering lipophilic compounds orally. In this project, two novel preparation strategies were proposed to fabricate GI-stable SLPN: 1) Bovine serum albumin (BSA) and dextran were first conjugated through Maillard reaction and the conjugates were exploited as macromolecular emulsifier and surface coating layer to prepare SLPN by a solvent diffusion and sonication method. In this approach, the multilayer structure was formed by self-assembly of BSA-dextran micelles to envelope solid lipid via a pH- and heating-induced facile process with simultaneous surface deposition of pectin; 2) Dextran was first oxidized and functionalized with more surface aldehyde groups, and then the SLPN was fabricated through in situ conjugation between oxidized dextran and BSA-emulsified solid lipid. Both types of SLPN were applied to encapsulate lipophilic bioactive compounds, including curcumin and astaxanthin (ASTN). The major objectives of this dissertation were to 1) systematically study the fabrication parameters in two preparation strategies to prepare SLPN; 2) comprehensively characterize the structural and colloidal properties of as-prepared two types of SLPN; 3) explore and compare the encapsulation and delivery applications of SLPN for lipophilic bioactive compounds, including curcumin and ASTN. In summary, the surface-functionalized SLPN could significantly improve the physicochemical properties of lipid nanoparticles and expand their potential as oral delivery systems for lipophilic bioactive compounds.


Development of Solid Lipid-polymer Hybrid Nanoparticles as Potential Oral Delivery Systems for Lipophilic Bioactive Compounds
Language: en
Pages:
Authors: Taoran Wang
Categories: Electronic dissertations
Type: BOOK - Published: 2019 - Publisher:

GET EBOOK

Solid lipid-polymer hybrid nanoparticles (SLPN) are nanocarriers made from a combination of polymers and lipids. By integrating the advantages of biocompatible
Lipid Nanoparticles: Production, Characterization and Stability
Language: en
Pages: 105
Authors: Rohan Shah
Categories: Medical
Type: BOOK - Published: 2014-08-28 - Publisher: Springer

GET EBOOK

​What are lipid nanoparticles? How are they structured? How are they formed? What techniques are best to characterize them? How great is their potential as dr
Lipid Polymer Hybrid Nanoparticles
Language: en
Pages: 0
Authors: Nayab Tahir
Categories: Medical
Type: BOOK - Published: 2019 - Publisher:

GET EBOOK

Applications of nanotechnology and material sciences emerge in the development of various novel drug delivery systems that have been proven as promising clinica
Bioactive Delivery Systems for Lipophilic Nutraceuticals
Language: en
Pages: 464
Authors: Ming Miao
Categories: Technology & Engineering
Type: BOOK - Published: 2023-06-26 - Publisher: Royal Society of Chemistry

GET EBOOK

There is growing interest in the food, supplements, cosmetics, and pharmaceutical industries in improving the healthiness of their products by incorporating lip
Lipid Nanoparticulate Drug Delivery Systems
Language: en
Pages: 0
Authors: Sudarshan Kumar Singh
Categories: Medical
Type: BOOK - Published: 2019 - Publisher:

GET EBOOK

Hybrid lipid polymers significantly changed the postulation of low or less bioavailability of conventional drug delivery systems. Several drug delivery systems